IP Library Granted Patent US 7,491,705
Granted Patent B2
US 7,491,705 · App. 10/582,015 · Granted Feb 17, 2009

Alpha-ketoamide derivative, and production method and use thereof

Assignee: Senju Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,491,705
App. No.
10/582,015
Granted
Feb 17, 2009
Kind
B2
Abstract

The present invention provides a compound represented by the formula (I): (wherein R 1 is a lower alkyl substituted by a lower alkoxy or a heterocyclic group, or a heterocyclic group; R 2 is a lower alkyl optionally substituted by a phenyl; and R 3 is a lower alkyl optionally substituted by a halogen, a lower alkoxy or a phenyl, or a fused polycyclic hydrocarbon group), which is well absorbed orally, exhibits durability of good blood level and has potent calpain inhibitory activity.

Claims (13)

1. A compound represented by the formula (I)

wherein R 1 is

(1) a group represented by the formula (IIb) in which n is an integer of 2 to 5,

(2) a straight or branched C 1-6 alkyl substituted by a pyridyl group optionally having a C 1-3 alkyl substituent on the pyridine ring, or

(3) a tetrahydrofuranyl group or a tetrahydropyranyl group;

R 2 is a straight or branched C 1-6 alkyl, optionally substituted by a phenyl; and

R 3 is hydrogen, a straight or branched C 1-6 alkyl or is selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

2. The compound as claimed in claim 1 , wherein R 1 is a group of the formula (IIb)

in which n is an integer of 2 to 5.

3. The compound as claimed in claim 1 , wherein R 3 is cyclopropyl.

4. The compound of claim 1 selected from the group consisting of ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester, ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 8-methoxy-3,6-dioxaoctyl ester, ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 11-methoxy-3,6,9-trioxaundecanyl ester, or ((1S)-1-((((1S)-1-benzyl-3-(cyclopropylamino)-2,3-dioxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 2-(pyridin-2-yl)ethyl ester.

5. A medicament comprising the compound as claimed in claim 1 .

6. The compound as claimed in claim 1 , which is ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester.

Assignments (2)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2006
From: SHIRASAKI, YOSHIHISA; MIYASHITA, HIROYUKI; NAKAMURA, MASAYUKI; INOUE, JUN
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 018089/0597 →
Priority Claims (2)
JP 2003-415764 · Dec 12, 2003 · national
JP 2004-234164 · Aug 11, 2004 · national
Continuity (1)
Related Publication 20070004643A1 · Jan 4, 2007